Higher rates of neo-adjuvant chemotherapy use among high-risk patients with advanced stage epithelial ovarian carcinoma is associated with improved outcomes

Dimitrios Nasioudis,Stefan Gysler,Nawar Latif,Emily Ko,Lori Cory,Sarah Kim,William Cliby,Robert Giuntoli

GYNECOLOGIC ONCOLOGY（2023）

引用 0|浏览5

暂无评分

摘要

Evaluate the oncologic outcomes of high-risk patients with advanced-stage epithelial ovarian carcinoma (EOC) according to facility-level adoption of neoadjuvant chemotherapy (NACT).

查看译文

关键词

epithelial ovarian carcinoma,chemotherapy,improved outcomes,neo-adjuvant,high-risk

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要